However, their long-term efficacy has been called into question: Weekly semaglutide injections led to 10.6% weight loss in five months
Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents (49)
Therefore, clinicians are asked to consider these therapies for PDAC risk reduction, provided there are no contraindications
Quite frankly, it tasted a lot better than the chicken dishes I could get from the (admittedly not great) Punjabi restaurant down the street from my house
Singh RK, Kumar P, Mahalingam K
The 3-month plan runs $129 first month, then $159 a month, billed every 12 weeks